These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 16639080)

  • 1. BRCA1 downregulation leads to premature inactivation of spindle checkpoint and confers paclitaxel resistance.
    Chabalier C; Lamare C; Racca C; Privat M; Valette A; Larminat F
    Cell Cycle; 2006 May; 5(9):1001-7. PubMed ID: 16639080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Weakened spindle checkpoint with reduced BubR1 expression in paclitaxel-resistant ovarian carcinoma cell line SKOV3-TR30.
    Fu Y; Ye D; Chen H; Lu W; Ye F; Xie X
    Gynecol Oncol; 2007 Apr; 105(1):66-73. PubMed ID: 17234259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dependence of paclitaxel sensitivity on a functional spindle assembly checkpoint.
    Sudo T; Nitta M; Saya H; Ueno NT
    Cancer Res; 2004 Apr; 64(7):2502-8. PubMed ID: 15059905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRCA1 is regulated by Chk2 in response to spindle damage.
    Chabalier-Taste C; Racca C; Dozier C; Larminat F
    Biochim Biophys Acta; 2008 Dec; 1783(12):2223-33. PubMed ID: 18804494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRCA1 modulates malignant cell behavior, the expression of survivin and chemosensitivity in human breast cancer cells.
    Promkan M; Liu G; Patmasiriwat P; Chakrabarty S
    Int J Cancer; 2009 Dec; 125(12):2820-8. PubMed ID: 19551867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRCA1-IRIS inactivation overcomes paclitaxel resistance in triple negative breast cancers.
    Blanchard Z; Paul BT; Craft B; ElShamy WM
    Breast Cancer Res; 2015 Jan; 17(1):5. PubMed ID: 25583261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deregulation of the spindle assembly checkpoint is associated with paclitaxel resistance in ovarian cancer.
    Chong T; Sarac A; Yao CQ; Liao L; Lyttle N; Boutros PC; Bartlett JMS; Spears M
    J Ovarian Res; 2018 Apr; 11(1):27. PubMed ID: 29618387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caspase-mediated specific cleavage of BubR1 is a determinant of mitotic progression.
    Kim M; Murphy K; Liu F; Parker SE; Dowling ML; Baff W; Kao GD
    Mol Cell Biol; 2005 Nov; 25(21):9232-48. PubMed ID: 16227576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of the mitotic checkpoint as a determinant of the efficacy of microtubule-targeted drugs in killing human cancer cells.
    Lee EA; Keutmann MK; Dowling ML; Harris E; Chan G; Kao GD
    Mol Cancer Ther; 2004 Jun; 3(6):661-9. PubMed ID: 15210851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitotic spindle checkpoint inactivation by trichostatin a defines a mechanism for increasing cancer cell killing by microtubule-disrupting agents.
    Dowling M; Voong KR; Kim M; Keutmann MK; Harris E; Kao GD
    Cancer Biol Ther; 2005 Feb; 4(2):197-206. PubMed ID: 15753652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving breast cancer sensitivity to paclitaxel by increasing aneuploidy.
    Rodrigues-Ferreira S; Nehlig A; Moindjie H; Monchecourt C; Seiler C; Marangoni E; Chateau-Joubert S; Dujaric ME; Servant N; Asselain B; de Cremoux P; Lacroix-Triki M; Arnedos M; Pierga JY; André F; Nahmias C
    Proc Natl Acad Sci U S A; 2019 Nov; 116(47):23691-23697. PubMed ID: 31685623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular senescence induced by aberrant MAD2 levels impacts on paclitaxel responsiveness in vitro.
    Prencipe M; Fitzpatrick P; Gorman S; Tosetto M; Klinger R; Furlong F; Harrison M; O'Connor D; Roninson IB; O'Sullivan J; McCann A
    Br J Cancer; 2009 Dec; 101(11):1900-8. PubMed ID: 19935801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of mitotic checkpoint genes in breast cancer cells with chromosomal instability.
    Yuan B; Xu Y; Woo JH; Wang Y; Bae YK; Yoon DS; Wersto RP; Tully E; Wilsbach K; Gabrielson E
    Clin Cancer Res; 2006 Jan; 12(2):405-10. PubMed ID: 16428479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of apoptosis by monastrol, an inhibitor of the mitotic kinesin Eg5, is independent of the spindle checkpoint.
    Chin GM; Herbst R
    Mol Cancer Ther; 2006 Oct; 5(10):2580-91. PubMed ID: 17041103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of centrosomal protein Nlp confers breast carcinoma resistance to paclitaxel.
    Zhao W; Song Y; Xu B; Zhan Q
    Cancer Biol Ther; 2012 Feb; 13(3):156-63. PubMed ID: 22353935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulators of mitotic arrest and ceramide metabolism are determinants of sensitivity to paclitaxel and other chemotherapeutic drugs.
    Swanton C; Marani M; Pardo O; Warne PH; Kelly G; Sahai E; Elustondo F; Chang J; Temple J; Ahmed AA; Brenton JD; Downward J; Nicke B
    Cancer Cell; 2007 Jun; 11(6):498-512. PubMed ID: 17560332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.
    Menendez JA; Vellon L; Colomer R; Lupu R
    Int J Cancer; 2005 May; 115(1):19-35. PubMed ID: 15657900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRCA1 regulates gene expression for orderly mitotic progression.
    Bae I; Rih JK; Kim HJ; Kang HJ; Haddad B; Kirilyuk A; Fan S; Avantaggiati ML; Rosen EM
    Cell Cycle; 2005 Nov; 4(11):1641-66. PubMed ID: 16258266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRCA1-mediated G2/M cell cycle arrest requires ERK1/2 kinase activation.
    Yan Y; Spieker RS; Kim M; Stoeger SM; Cowan KH
    Oncogene; 2005 May; 24(20):3285-96. PubMed ID: 15735702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G2 cell cycle arrest, down-regulation of cyclin B, and induction of mitotic catastrophe by the flavoprotein inhibitor diphenyleneiodonium.
    Scaife RM
    Mol Cancer Ther; 2004 Oct; 3(10):1229-37. PubMed ID: 15486190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.